Omega Fund Management »

Beta Bionics shares owned by Omega Fund Management

Quarter-by-quarter ownership of Beta Bionics (BBNX) shares owned by Omega Fund Management from 13F filings

Historical chart of Omega Fund Management investment in Beta Bionics

Tip: Access up to 7 years of quarterly data

All positions including Beta Bionics held by Omega Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beta Bionics by Omega Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $38M 1.9M 19.87
2025-06-30 $29M 2.0M 14.56
2025-03-31 $24M 2.0M 12.24

More positions owned by Omega Fund Management

Kestra Med Technologies Common Stock (KMTS)
Beta Bionics Common Stock (BBNX)
BridgeBio Oncology Therapeutics Common Stock
Bicara Therapeutics Common Stock (BCAX)
Nuvation Bio Common Stock Class A (NUVB)
Upstream Bio Common Stock (UPB)
ImageneBio Common Stock
enGene Holdings Common Stock (ENGN)
Sana Biotechnology Common Stock (SANA)
Alumis Common Stock (ALMS)
Replimune Group Common Stock (REPL)
enGene Holdings Warrant (ENGNW)

View all positions for Omega Fund Management

Top funds holding Beta Bionics

Eventide Asset Management
Farallon Capital Management
Wellington Management Company
Soleus Capital Management
Sands Capital Ventures
Rtw Investments
Morgan Stanley
BlackRock
Vanguard Group
Omega Fund Management
Deerfield Management Company
Driehaus Capital Management
Geode Capital Management
State Street Corporation
Millennium Management

View all funds holding Beta Bionics